| Phase 12 trials |
|
Phase 1
|
NCT00245024 |
Nov 2005 → Aug 2007 |
breast cancer |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01515137 |
Nov 2005 → Sep 2014 |
head and neck squamous cell carcinoma |
University of Pittsburgh |
Completed
|
No outcome recorded
|
| Phase 211 trials · 2 missed |
|
Phase 2
|
NCT04207944 |
Jul 2020 → Jul 2026 overdue |
pancreatic intraductal papillary-mucinous neoplasm |
Duke University |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01636128 |
Mar 2014 → Mar 2016 |
— |
Cancer Prevention Pharmaceuticals, Inc. |
Withdrawn
|
No outcome recorded
Stop: Business |
|
Phase 2
|
NCT01843179 |
Jan 2014 |
acute myeloid leukemia |
Massachusetts General Hospital |
Withdrawn
|
No outcome recorded
Stop: Business |
|
Phase 2
|
NCT01761877 |
Dec 2012 → Feb 2019 |
cancer, hypertensive disorder |
Stony Brook University |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00841204 |
Feb 2009 → Feb 2011 |
precancerous condition |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00755976 |
Aug 2007 → May 2010 |
cutaneous melanoma |
Cancer Trials Ireland |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00368927 |
Aug 2006 → May 2010 |
nicotine dependence, non-small cell lung carcinoma, precancerous condition |
National Cancer Institute (NCI) |
Completed
|
Missed primary
|
|
Phase 2
|
NCT00319007 |
Apr → Dec 2006 |
classic or attenuated familial adenomatous polyposis |
Radboud University Medical Center |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT00335504 |
Mar 2006 → Apr 2009 |
colon carcinoma, precancerous condition, rectal carcinoma |
National Cancer Institute (NCI) |
Completed
|
Missed primary
|
|
Phase 2
|
NCT00068419 |
Feb 2004 → Apr 2010 |
desmoid tumor |
Children's Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00039520 |
Jan 2002 → Jun 2004 |
breast cancer |
Fox Chase Cancer Center |
Completed
|
No outcome recorded
|
|
| Phase 33 trials |
|
Phase 3
|
NCT01349881 |
Aug 2013 → Sep 2027 expected |
colorectal neoplasm |
SWOG Cancer Research Network |
Active not recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT01245816 |
Mar 2011 → May 2013 |
classic familial adenomatous polyposis |
Cancer Prevention Pharmaceuticals, Inc. |
Withdrawn
|
No outcome recorded
|
|
Phase 3
|
NCT00118365 |
Jul 1998 → Aug 2008 |
precancerous condition |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase not applicable4 trials |
| — |
NCT00343629 |
Apr 2006 → Oct 2007 |
cancer of unknown primary site |
Mayo Clinic |
Completed
|
No outcome recorded
|
| — |
NCT00299195 |
Feb 2006 → Jan 2020 |
benign neoplasm, oral mucosa leukoplakia |
Memorial Sloan Kettering Cancer Center |
Completed
|
No outcome recorded
|
| — |
NCT00176618 |
Apr 2004 → Jun 2007 |
— |
University of Medicine and Dentistry of New Jersey |
Terminated
|
No outcome recorded
|
| — |
NCT00003365 |
Aug 1996 → Jul 2006 |
colorectal cancer |
University of Medicine and Dentistry of New Jersey |
Terminated
|
No outcome recorded
|
| Comparator or background therapy6 trials |
|
Phase 2
|
NCT04823052 Comparator |
May → Oct 2022 |
fragile X syndrome |
Healx Limited |
Withdrawn
|
No outcome recorded
Stop: Enrollment |
|
Phase 2
|
NCT04542135 Comparator |
Nov 2020 → Apr 2025 |
breast cancer |
Alison Stopeck |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01856322 Comparator |
Apr 2013 → Jan 2015 |
colorectal adenocarcinoma, metastasis from malignant tumor of colon |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
Stop: Enrollment |
|
Phase 2
|
NCT01187901 Comparator |
Apr 2010 → Jun 2014 |
classic or attenuated familial adenomatous polyposis |
University of Utah |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00392665 Comparator |
Oct 2006 → Aug 2012 |
head and neck squamous cell carcinoma |
Massachusetts General Hospital |
Terminated
|
No outcome recorded
Stop: Enrollment |
|
Phase 2
|
NCT00062023 Comparator |
Jun 2003 → Apr 2005 |
colorectal cancer |
M.D. Anderson Cancer Center |
Terminated
|
No outcome recorded
|
|